On December 11, 2018, a historic moment took place in Washington D.C. For the first time since the early days of the country, lawmakers voted on sweeping changes to hemp production in the United States. With the stroke of a pen made from hemp, Senator Mitch McConnell (R-KY) signed off on the 2018 Farm Bill….

In recent years, the legal status of marijuana, CBD, and hemp have been common topics of discussion on the local, national, and international scale. As legalization in its many forms has spread in the United States, the conversation around cannabis and its effects has become more nuanced and commonplace. Recently, cannabinoid research company Verda Bio…

Neil Juneja featured on Cannabis Industry Podcast Last week, School for Startups Radio interviewed Neil Juneja about his experience in the legal cannabis industry. In the episode, Neil talks about the difference between recreational and medical cannabis, and what the implications are for the medical industry in states  that legalize medical and recreational marijuana. He…

mg Magazine’s Top 30 Cannabis Attorneys Last week, mg Magazine released a list called “30 Powerful Litigators You Should Know”. We are pleased to see that the editors listed Orion Inskip from Gleam Law as one of the top contenders. As a cannabis attorney, Orion has extensive litigation experience in cannabis law and has negotiated…

For the October edition of Start Up Stoners, Neil Juneja spoke to Brettski and Cody Chase about his experience in the cannabis legal industry. With a background as a Lighting Designer at major concerts, Neil saw white space in the realm of legal advice for lighting and applied the same idea to the green industry….

Price Hikes for Hemp Licenses Could be Coming in Washington State  Written by Orion Inskip, Attorney at Gleam Law with focus on CBD Law. Hemp, once a staple of American industry, is slowly taking hold as a cash crop. The aftermath of 1998’s legalization of the importation of hemp has shown that there is a…

CBD Status Quo, in Limbo Despite the baited anticipation for announcements from the DEA and Congress this week, the announcements from Congress and the DEA today change nothing about CBD’s legal status in the eyes of the federal government.   FDA Approved Epidiolex…Now What? Once the FDA approved Epidiolex, a medicine derived from CBD, as…

Ohio Takes a Swing at CBD in Medical Cannabis Market Written by Orion Inskip, Attorney at Gleam Law that specializes in CBD. Yet another state takes a hardline stance against CBD sold outside the regulated medical cannabis market. With the Ohio Pharmacy Board’s recent “Clarification on Cannabidiol (CBD) Oil”, Ohio has joined states like California…

California Department of Public Health Prohibits CBD in Food Products By Orion Inskip, Attorney at Gleam Law PLLC According to a recent FAQ released by the California Department of Public Health’s Food & Drug Branch (CDPH-FDB), CBD is prohibited from use in any food product sold outside of the legal cannabis industry in the state….

BREAKING: FDA Approves CBD-Based Medicine Derived from Marijuana Written by Orion Inskip, Attorney at Gleam Law, PLLC.  The Food and Drug Administration (FDA) has approved Epidiolex, an epilepsy medicine derived from marijuana. The drug’s active ingredient is a non-psychoactive cannabinoid known as cannabidiol (CBD) and is the first marijuana-based medication approved by the FDA. This…